Clinical Pearls

In this interview from the NP Institute annual meeting, Co-Chair Andrew Penn, NP, discusses the importance of neurobiological foundations in everyday prescribing.

Anxiety in women is often misunderstood—even in psychiatric clinical settings. Ahead of the 2025 Psych Congress NP Institute, Psych Congress Network connected with Moushumi Mukerji, MSN, PMHNP-BC, CNM, to discuss some of the key clinical...

Moushumi Mukerji, MSN, PMHNP-BC, CNM, and Vanessa Joy Walker, CPC, MPH Candidate discuss some of the key clinical takeaways from their session on treating anxiety in women patients, presented at the 2025 Psych Congress NP Institute.

In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN explains deprescribing and how it has a place even when treating patients living with serious mental illness like schizophrenia.

Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia.

Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.